China unveils new drug patenting rules

China has introduced new measures to enforce a patent linkage system and proposed draft rules on how a patent owner can challenge the approval of a drug.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Boehringer hits China’s Qilu with cancer drug patent suit

4 February 2021 Chinese drug maker Qilu’s proposed generic version of a cancer treatment infringes three patents, according to a lawsuit filed by Boehringer Ingelheim.

Big Pharma

China approves three Gilead remdesivir patents for COVID-19 treatment

27 February 2020 US-based Gilead Sciences has been granted three Chinese patents connected to possible COVID-19 treatment remdesivir, reported He Zhimin, the deputy director of China’s National Intellectual Property Administration.

More on this story

Big Pharma

Boehringer hits China’s Qilu with cancer drug patent suit

4 February 2021 Chinese drug maker Qilu’s proposed generic version of a cancer treatment infringes three patents, according to a lawsuit filed by Boehringer Ingelheim.

Big Pharma

China approves three Gilead remdesivir patents for COVID-19 treatment

More on this story

Big Pharma

Boehringer hits China’s Qilu with cancer drug patent suit

4 February 2021 Chinese drug maker Qilu’s proposed generic version of a cancer treatment infringes three patents, according to a lawsuit filed by Boehringer Ingelheim.

Big Pharma

China approves three Gilead remdesivir patents for COVID-19 treatment